Generation of Recombinant Human Parainfluenza Virus Type 1 Vaccine Candidates by Importation of Temperature-Sensitive and Attenuating Mutations from Heterologous Paramyxoviruses

Human parainfluenza virus type 1 (HPIV1) is a significant cause of respiratory tract disease in infants and young children for which a vaccine is needed. In the present study, we sought to attenuate HPIV1 by the importation of one or more known attenuating point mutations from heterologous paramyxov...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Newman, Jason T., Riggs, Jeffrey M., Surman, Sonja R., McAuliffe, Josephine M., Mulaikal, Teresa A., Collins, Peter L., Murphy, Brian R., Skiadopoulos, Mario H.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2004
Soggetti:	Vaccines and Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC369514/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14747566/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.4.2017-2028.2004
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!